Rasagiline mesylate
-
Catalog number2237-250
-
PricePlease ask
-
Size250 mg
-
-
Alternative_name(1R)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine methanesulfonate
-
DescriptionRasagiline is a selective and irreversible inhibitor of monoamine oxidase (MAO) that has been used as a monotherapy in early Parkinson’s disease or as an adjunct therapy in more advanced cases.
-
CAS Number161735-79-1
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₂H₁₃N ∙ CH₃SO₃H
-
Molecular Weight267.34
-
Cell PermeableYes
-
Purity≥99%
-
SolubilitiesDMSO (>20 mg/ml) or H₂O (>20 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA selective and reversible monoamine oxidase (MAO) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD08460604
-
PubChem CID3052775
-
SMILESCS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12
-
InChiInChI=1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1
-
InChi KeyJDBJJCWRXSVHOQ-UTONKHPSSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameRasagiline mesylate
-
Alternative nameRasagiline mesylate
-